These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 8139596)

  • 1. Atypical blepharospasm responsive to sodium valproate.
    Chand RP; Park DM
    Mov Disord; 1994 Jan; 9(1):116-7. PubMed ID: 8139596
    [No Abstract]   [Full Text] [Related]  

  • 2. Blepharospasm--successful treatment with baclofen and sodium valproate. A case report.
    Sandyk R
    S Afr Med J; 1983 Dec; 64(24):955-6. PubMed ID: 6417803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Further therapeutic possibilities with valproic acid (Convulex)].
    Auff E; Holzner F; Wessely P
    Wien Med Wochenschr; 1985 Sep; 135(17):421-3. PubMed ID: 3933186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of juvenile myoclonic epilepsy with low-dose sodium valproate].
    De Toffol B; Autret A
    Rev Neurol (Paris); 1996 Nov; 152(11):708-10. PubMed ID: 9033947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety, effectiveness, and duration of effect of BOTOX after switching from Dysport for blepharospasm, cervical dystonia, and hemifacial spasm dystonia, and hemifacial spasm.
    Bihari K
    Curr Med Res Opin; 2005 Mar; 21(3):433-8. PubMed ID: 15811212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low dose of sodium divalproate for the treatment of migraine.
    Fragoso YD
    MedGenMed; 2003 Mar; 5(1):32. PubMed ID: 12827093
    [No Abstract]   [Full Text] [Related]  

  • 7. [The action of sodium valproate in central pain syndromes].
    Grafova VN; Danilova EI; Reshetniak VK
    Eksp Klin Farmakol; 1994; 57(2):8-11. PubMed ID: 8205057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Valproate monotherapy in the treatment of civilian patients with non-combat-related posttraumatic stress disorder: an open-label study.
    Otte C; Wiedemann K; Yassouridis A; Kellner M
    J Clin Psychopharmacol; 2004 Feb; 24(1):106-8. PubMed ID: 14709964
    [No Abstract]   [Full Text] [Related]  

  • 9. Acute psychosis associated with levetiracetam.
    Youroukos S; Lazopoulou D; Michelakou D; Karagianni J
    Epileptic Disord; 2003 Jun; 5(2):117-9. PubMed ID: 12875956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bell's palsy-induced blepharospasm relieved by passive eyelid closure and responsive to apomorphine.
    Cattaneo L; Chierici E; Pavesi G
    Clin Neurophysiol; 2005 Oct; 116(10):2348-53. PubMed ID: 16098807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A 12-week, open, randomized trial comparing sodium valproate to lithium in patients with bipolar I disorder suffering from a manic episode.
    Bowden C; Göğüş A; Grunze H; Häggström L; Rybakowski J; Vieta E
    Int Clin Psychopharmacol; 2008 Sep; 23(5):254-62. PubMed ID: 18703934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of rapid IV administration of valproic acid for status epilepticus.
    Limdi NA; Shimpi AV; Faught E; Gomez CR; Burneo JG
    Neurology; 2005 Jan; 64(2):353-5. PubMed ID: 15668440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety of rapid intravenous loading of valproate.
    Limdi NA; Knowlton RK; Cofield SS; Ver Hoef LW; Paige AL; Dutta S; Faught E
    Epilepsia; 2007 Mar; 48(3):478-83. PubMed ID: 17319914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful treatment of blepharospasm with tandospirone, a 5-HT1A partial agonist: a case report.
    Takahashi T; Murata T; Wada Y
    Mov Disord; 2008 Jan; 23(1):151-2. PubMed ID: 17987656
    [No Abstract]   [Full Text] [Related]  

  • 15. Low-dose valproate: a new treatment for cyclothymia, mild rapid cycling disorders, and premenstrual syndrome.
    Jacobsen FM
    J Clin Psychiatry; 1993 Jun; 54(6):229-34. PubMed ID: 8331092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health-economic implications of the onset of action of antimanic agents.
    Keck PE; McElroy SL; Bennett JA
    J Clin Psychiatry; 1996; 57 Suppl 13():13-8; discussion 19-22. PubMed ID: 8970501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Valproate protein binding following rapid intravenous administration of high doses of valproic acid in patients with epilepsy.
    Dutta S; Faught E; Limdi NA
    J Clin Pharm Ther; 2007 Aug; 32(4):365-71. PubMed ID: 17635338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Botulinum toxin type A purified neurotoxin complex for the treatment of blepharospasm: a dose-response study measuring eyelid force.
    Iwashige H; Nemeto Y; Takahashi H; Maruo T
    Jpn J Ophthalmol; 1995; 39(4):424-31. PubMed ID: 8926651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of purified botulinum toxin type A (Dysport) for the treatment of benign essential blepharospasm: a randomized, placebo-controlled, phase II trial.
    Truong D; Comella C; Fernandez HH; Ondo WG;
    Parkinsonism Relat Disord; 2008; 14(5):407-14. PubMed ID: 18325821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different effects of valproate on methamphetamine- and cocaine-induced behavioral sensitization in mice.
    Li JX; Han R; Deng YP; Chen SQ; Liang JH
    Behav Brain Res; 2005 Jun; 161(1):125-32. PubMed ID: 15904719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.